Researchers have identified a potential link between a common pneumonia bacterium and Alzheimer’s disease. The study suggests that infection-driven inflammation may contribute to nerve damage and memory decline.

Scientists at Cedars-Sinai Medical Center discovered that Chlamydia pneumoniae can enter the retina and brain. Once inside these tissues, the bacterium triggers immune responses. Consequently, inflammation increases and nerve cells begin to deteriorate.

🧬 Evidence of Infection in the Brain

Researchers examined brain and retinal tissue from people with normal cognition, mild cognitive impairment and Alzheimer’s disease. They found significantly higher levels of the bacterium in those with Alzheimer’s.

Moreover, participants carrying the high-risk APOE4 gene variant showed even greater bacterial presence. These individuals also experienced more severe cognitive decline. Therefore, the findings suggest a possible interaction between genetic risk and infection.

Scientists have long suspected that infection may influence Alzheimer’s progression. However, this study strengthens the evidence by identifying the bacterium directly in affected tissues.

🔬 Laboratory and Animal Findings

The team also studied human nerve cells in laboratory experiments. They introduced Chlamydia pneumoniae and monitored cellular responses. As a result, infected cells produced more amyloid-beta protein, which is strongly linked to Alzheimer’s disease.

In addition, researchers tested the bacterium in mice genetically engineered to develop Alzheimer’s-like symptoms. The infected mice showed increased brain inflammation. They also developed more amyloid deposits and experienced faster cognitive decline.

Because inflammation damages neurons over time, the infection may accelerate neurodegeneration. Therefore, scientists believe that controlling chronic infection could slow disease progression.

👁️ Retina as an Early Indicator

Importantly, the bacterium also appeared in retinal tissue. The retina connects directly to the brain and shares similar nerve structures. Consequently, researchers suggest that eye examinations could help detect early Alzheimer’s-related changes.

If doctors identify bacterial markers in the retina, they may diagnose risk earlier. Early detection could allow earlier intervention. That shift would significantly improve patient outcomes.

💡 Implications for Treatment

The findings open new possibilities for therapy. Researchers suggest that antibiotics or anti-inflammatory treatments may help reduce bacterial impact. However, they emphasise that further clinical studies are necessary.

Because Alzheimer’s remains complex and multifactorial, infection likely represents one part of a larger process. Nevertheless, targeting inflammation could provide a meaningful treatment pathway.

🔎 Future Research Directions

Scientists now plan to expand their research to larger populations. They aim to determine how widespread bacterial involvement may be in Alzheimer’s cases. In addition, they will study whether similar mechanisms operate in other neurodegenerative diseases.

While the research does not prove direct causation, it strengthens the theory that chronic infection and immune activation contribute to brain disease.

As investigations continue, the study adds an important piece to the Alzheimer’s puzzle. Moreover, it highlights the growing link between infectious disease and neurological decline.